MedPath

Comparative trials of Olopatadine and Fexofenadine on histamine iontophoresis induced urticaria

Phase 4
Conditions
rticaria
Registration Number
JPRN-UMIN000007182
Lead Sponsor
Faculty of Medicine, University of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1. Participate in other trial within 120 days. 2. Taking some medicine 3. History of drug allergy 4. History of sever skin disease 5. History of liver disease 6. History of heart disease 7. History of respiratory disease 8. History of digestive disease 9. History of kidney or cerebrovascular disease 10. History of malignancy 11. Low responder to histamine iontophoresis 12. Heavy drinker 13. Participant who judged as inadequate for this trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath